3.06
price down icon2.55%   -0.08
pre-market  プレマーケット:  3.06  
loading
前日終値:
$3.14
開ける:
$3.1
24時間の取引高:
1.61M
Relative Volume:
1.52
時価総額:
$203.56M
収益:
$488.00K
当期純損益:
$-41.44M
株価収益率:
-3.2903
EPS:
-0.93
ネットキャッシュフロー:
$-31.47M
1週間 パフォーマンス:
-19.47%
1か月 パフォーマンス:
-27.83%
6か月 パフォーマンス:
+23.89%
1年 パフォーマンス:
-46.60%
1日の値動き範囲:
Value
$2.94
$3.13
1週間の範囲:
Value
$2.94
$3.81
52週間の値動き範囲:
Value
$2.01
$6.38

Cardiff Oncology Inc Stock (CRDF) Company Profile

Name
名前
Cardiff Oncology Inc
Name
セクター
Healthcare (1165)
Name
電話
858-952-7570
Name
住所
11055 FLINTKOTE AVENUE, SAN DIEGO, CA
Name
職員
33
Name
次回の収益日
2024-10-31
Name
最新のSEC提出書
Name
CRDF's Discussions on Twitter

CRDF を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
CRDF
Cardiff Oncology Inc
3.06 203.56M 488.00K -41.44M -31.47M -0.93
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.74 124.48B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
617.00 67.45B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
567.09 34.59B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
255.76 33.10B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
271.04 29.15B 3.81B -644.79M -669.77M -6.24

Cardiff Oncology Inc Stock (CRDF) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-09-06 開始されました Craig Hallum Buy
2022-01-05 開始されました William Blair Outperform
2021-12-08 開始されました Robert W. Baird Outperform
2021-08-09 再開されました Maxim Group Buy
2020-10-22 開始されました H.C. Wainwright Buy
2020-10-08 開始されました Piper Sandler Overweight
すべてを表示

Cardiff Oncology Inc (CRDF) 最新ニュース

pulisher
Apr 01, 2025

Charles Schwab Investment Management Inc. Sells 19,629 Shares of Cardiff Oncology, Inc. (NASDAQ:CRDF) - Defense World

Apr 01, 2025
pulisher
Mar 26, 2025

Is Cardiff Oncology, Inc. (CRDF) The Hot Biotech Stock Under $5? - Insider Monkey

Mar 26, 2025
pulisher
Mar 24, 2025

Bank of New York Mellon Corp Increases Stock Holdings in Cardiff Oncology, Inc. (NASDAQ:CRDF) - Defense World

Mar 24, 2025
pulisher
Mar 21, 2025

10 Hot Biotech Stocks Under $5 - Insider Monkey

Mar 21, 2025
pulisher
Mar 12, 2025

Is Cardiff Oncology 15% bump due to positive clinical trials or a short squeeze? - Mugglehead

Mar 12, 2025
pulisher
Mar 10, 2025

Cardiff Oncology Inc (CRDF) Q4 2024 Earnings Report Preview: Wha - GuruFocus.com

Mar 10, 2025
pulisher
Mar 10, 2025

Future Industry Growth Of Metastatic Prostate Cancer Market - openPR

Mar 10, 2025
pulisher
Mar 10, 2025

Rhumbline Advisers Buys 10,290 Shares of Cardiff Oncology, Inc. (NASDAQ:CRDF) - Defense World

Mar 10, 2025
pulisher
Mar 08, 2025

Why the Global Cancer Market Could Surpass $900 Billion-And the Stocks Leading the Charge - The Malaysian Reserve

Mar 08, 2025
pulisher
Mar 08, 2025

Why the Global Cancer Market Could Surpass $900 Billion--And the Stocks Leading the Charge - Canada NewsWire

Mar 08, 2025
pulisher
Mar 05, 2025

Cardiff Oncology’s Earnings Call: Optimism Amid Challenges - MSN

Mar 05, 2025
pulisher
Mar 05, 2025

Financial Review: Kymera Therapeutics (NASDAQ:KYMR) vs. Cardiff Oncology (NASDAQ:CRDF) - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

All You Need to Know About Cardiff Oncology (CRDF) Rating Upgrade to Buy - Nasdaq

Mar 04, 2025
pulisher
Mar 03, 2025

Q1 Earnings Forecast for CRDF Issued By William Blair - Defense World

Mar 03, 2025
pulisher
Mar 03, 2025

Cardiff Oncology (NASDAQ:CRDF) Price Target Raised to $17.00 - Defense World

Mar 03, 2025
pulisher
Mar 01, 2025

HC Wainwright Forecasts Strong Price Appreciation for Cardiff Oncology (NASDAQ:CRDF) Stock - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

Cardiff Oncology Full Year 2024 Earnings: Beats Expectations - Yahoo Finance

Mar 01, 2025
pulisher
Feb 28, 2025

Cardiff Oncology (NASDAQ:CRDF) Announces Quarterly Earnings Results - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Cardiff Oncology plans mixed shelf offering - MSN

Feb 28, 2025
pulisher
Feb 28, 2025

Cardiff Oncology, Inc. (NASDAQ:CRDF) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 28, 2025
pulisher
Feb 28, 2025

Cardiff Oncology Inc (CRDF) Q4 2024 Earnings Call Highlights: Financial Fortification and ... - Yahoo Finance

Feb 28, 2025
pulisher
Feb 27, 2025

Cardiff Oncology Highlights Progress in Cancer Trials - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Cardiff Oncology Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 27, 2025
pulisher
Feb 27, 2025

Cardiff Oncology (CRDF) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Feb 27, 2025
pulisher
Feb 27, 2025

Earnings call transcript: Cardiff Oncology Q4 2024 highlights strategic advances - Investing.com

Feb 27, 2025
pulisher
Feb 27, 2025

Cardiff Oncology Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update - The Manila Times

Feb 27, 2025
pulisher
Feb 27, 2025

Cardiff Oncology Reports Positive Initial Efficacy Data for Onvansertib in Metastatic Colorectal Cancer and Secures $40 Million Financing - Nasdaq

Feb 27, 2025
pulisher
Feb 27, 2025

Cardiff Oncology, Inc. SEC 10-K Report - TradingView

Feb 27, 2025
pulisher
Feb 26, 2025

Cardiff Oncology Inc (CRDF) Q4 2024 Earnings Report Preview: What To Look For - Yahoo Finance

Feb 26, 2025
pulisher
Feb 25, 2025

Cardiff Oncology Inc expected to post a loss of 24 cents a shareEarnings Preview - TradingView

Feb 25, 2025
pulisher
Feb 25, 2025

Cardiff Oncology (CRDF) Projected to Post Earnings on Thursday - MarketBeat

Feb 25, 2025
pulisher
Feb 24, 2025

Cardiff Oncology to Present at Upcoming Investor Conferences - The Manila Times

Feb 24, 2025
pulisher
Feb 24, 2025

Can Cardiff Oncology's New Colorectal Cancer Approach Transform Treatment? CEO to Reveal Strategy - StockTitan

Feb 24, 2025
pulisher
Feb 23, 2025

Critical Contrast: Cardiff Oncology (NASDAQ:CRDF) versus Vir Biotechnology (NASDAQ:VIR) - Defense World

Feb 23, 2025
pulisher
Feb 22, 2025

Cardiff Oncology (CRDF) to Release Earnings on Thursday - Defense World

Feb 22, 2025
pulisher
Feb 20, 2025

Cardiff Oncology to Report Fourth Quarter 2024 Results and Provide Business Update - The Manila Times

Feb 20, 2025
pulisher
Feb 20, 2025

Can Cardiff Oncology's Q4 Earnings Reveal New Cancer Drug Progress? - StockTitan

Feb 20, 2025
pulisher
Feb 20, 2025

Bullish Cardiff Oncology Insiders Rewarded As Their Investment Rises To US$1.81m - Yahoo Finance

Feb 20, 2025
pulisher
Feb 19, 2025

Cardiff Oncology, Inc. (NASDAQ:CRDF) Sees Significant Growth in Short Interest - MarketBeat

Feb 19, 2025
pulisher
Feb 19, 2025

Taking on analysts’ expectations and winning: Cardiff Oncology Inc (CRDF) - SETE News

Feb 19, 2025
pulisher
Feb 18, 2025

Cardiff Oncology: Pioneering RAS-Mutated Cancer Therapies With Onvansertib (NASDAQ:CRDF) - Seeking Alpha

Feb 18, 2025
pulisher
Feb 18, 2025

Cardiff Oncology, Inc. (NASDAQ:CRDF) Sees Significant Increase in Short Interest - Defense World

Feb 18, 2025
pulisher
Feb 14, 2025

SG Americas Securities LLC Sells 6,103 Shares of Cardiff Oncology, Inc. (NASDAQ:CRDF) - Defense World

Feb 14, 2025
pulisher
Feb 13, 2025

Compass Therapeutics (NASDAQ:CMPX) & Cardiff Oncology (NASDAQ:CRDF) Critical Review - Defense World

Feb 13, 2025
pulisher
Feb 12, 2025

Cardiff Oncology Inc (CRDF) Stock: Exploring a Year of Highs, Lows, and Trading Volume - The InvestChronicle

Feb 12, 2025

Cardiff Oncology Inc (CRDF) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$67.94
price down icon 3.89%
$72.00
price down icon 5.62%
$31.17
price up icon 0.13%
$18.80
price down icon 2.54%
$90.29
price down icon 0.85%
biotechnology ONC
$271.04
price down icon 0.42%
大文字化:     |  ボリューム (24 時間):